x
Cure., a Deerfield affiliate and premier healthcare innovation ecosystem, recently launched the Cure Innovation Index. To our knowledge, this is the first systematic ranking of U.S. biomedical institutions by an array of critical factors associated with the successful translation of scientific research into real-world health impact.
The Index ranks the top 303 U.S. institutions using an evidence-based framework to quantify key elements that aims to help enable researchers to turn scientific discoveries into healthcare solutions with commercial and public health potential.
Translating scientific breakthroughs into new therapies for patients
The University of Illinois Urbana-Champaign and healthcare investment firm Deerfield Management have partnered to launch Alma Therapeutics.
Alma was created with the goal to translate breakthrough science developed at Illinois into innovative medicines for patients. By combining Illinois’ world-class research ecosystem with Deerfield’s scientific and investment experience, this partnership is designed to accelerate promising discoveries toward clinical development.
The partnership is housed within the Carl R. Woese Institute for Genomic Biology (IGB), strengthening collaboration across campus while keeping therapeutic development at the center.
Deerfield is an investment management firm committed to advancing healthcare through investment, intelligence, and philanthropy. The Deerfield ecosystem is headquartered at Cure, a premier healthcare innovation campus in New York City, and includes Deerfield Discovery and Development (3DC), the firm's internal research & development engine, and Deerfield Intelligence, the firm's data, technology, and artificial intelligence arm.
Deerfield works across the healthcare ecosystem to connect people, capital, ideas, and technology in bold, collaborative, and inclusive ways. For more information, please visit www.deerfield.com.
